{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:05:14Z","timestamp":1789679114029,"version":"4.0.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1097\/mph.0b013e318041f112","type":"journal-article","created":{"date-parts":[[2007,4,2]],"date-time":"2007-04-02T04:10:09Z","timestamp":1175487009000},"page":"222-226","source":"Crossref","is-referenced-by-count":27,"title":["Feasibility and Toxicity of Intrathecal Liposomal Cytarabine in 5 Children and Young Adults With Refractory Neoplastic Meningitis"],"prefix":"10.1097","volume":"29","author":[{"given":"Martin","family":"Benesch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Sovinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herwig","family":"Lackner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Schwinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Gadner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210227","first-page":"3310","article-title":"Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group","volume":"95","author":"Schrappe","year":"2000","journal-title":"Blood"},{"key":"R2-4-20210227","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1038\/sj.leu.2403920","article-title":"Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials","volume":"19","author":"Creutzig","year":"2005","journal-title":"Leukemia"},{"key":"R3-4-20210227","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1200\/JCO.1993.11.2.279","article-title":"Does cranial irradiation reduce the risk for bone marrow relapse in acute myelogenous leukemia? Unexpected results of the Childhood Acute Myelogenous Leukemia Study BFM-87","volume":"11","author":"Creutzig","year":"1993","journal-title":"J Clin Oncol"},{"key":"R4-4-20210227","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1200\/JCO.1999.17.3.832","article-title":"Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study","volume":"17","author":"Zeltzer","year":"1999","journal-title":"J Clin Oncol"},{"key":"R5-4-20210227","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0360-3016(99)00369-7","article-title":"Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT \u201891","volume":"46","author":"Kortmann","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R6-4-20210227","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1200\/JCO.2004.01.046","article-title":"Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis","volume":"22","author":"Bomgaars","year":"2004","journal-title":"J Clin Oncol"},{"key":"R7-4-20210227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-200544010-00001","article-title":"Pharmacokinetics following intraventricular administration of chemotherapy in patients with neoplastic meningitis","volume":"44","author":"Fleischhack","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"R8-4-20210227","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1023\/A:1005903414734","article-title":"Prophylaxis and treatment of neoplastic meningeosis in childhood acute lymphoblastic leukemia","volume":"38","author":"Schrappe","year":"1998","journal-title":"J Neurooncol"},{"key":"R9-4-20210227","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1056\/NEJMoa042176","article-title":"Treatment of early childhood medulloblastoma by postoperative chemotherapy alone","volume":"352","author":"Rutkowski","year":"2005","journal-title":"N Engl J Med"},{"key":"R10-4-20210227","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1023\/A:1025633704071","article-title":"Feasibility of long-term intraventricular therapy with mafosfamide (n=26) and etoposide (n=11): experience in 26 children with disseminated malignant brain tumors","volume":"64","author":"Slavc","year":"2003","journal-title":"J Neurooncol"},{"key":"R11-4-20210227","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1347::AID-CNCR34>3.0.CO;2-M","article-title":"Survival of patients with high grade glioma treated with intrathecal thiotriethylenephosphoramide for ependymal or leptomeningeal gliomatosis","volume":"86","author":"Witham","year":"1999","journal-title":"Cancer"},{"key":"R12-4-20210227","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1200\/JCO.2005.06.053","article-title":"Intrathecal mafosfamide: a preclinical pharmacology and phase I trial","volume":"23","author":"Blaney","year":"2005","journal-title":"J Clin Oncol"},{"key":"R13-4-20210227","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11060-006-9218-x","article-title":"A pharmacokinetic study of intra-CSF administered encapsulated cytarabine (DepoCyt\u00ae) for the treatment of neoplastic meningitis in patients with leukemia, lymphoma, or solid tumors as part of a phase III study","volume":"81","author":"Phuphanich","year":"2007","journal-title":"J Neurooncol"},{"key":"R14-4-20210227","first-page":"3394","article-title":"A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyte\u00ae) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors","volume":"5","author":"Glantz","year":"1999","journal-title":"Clin Cancer Res"},{"key":"R15-4-20210227","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1023\/A:1015752331041","article-title":"An open label trial of sustained-release cytarabine (DepoCytTM) for the intrathecal treatment of solid tumor neoplastic meningitis","volume":"57","author":"Jaeckle","year":"2002","journal-title":"J Neurooncol"},{"key":"R16-4-20210227","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000069773","article-title":"Biochemical and clinical aspects of methotrexate neurotoxicity","volume":"49","author":"Vezmar","year":"2003","journal-title":"Chemotherapy"},{"key":"R17-4-20210227","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/1097-0142(19840501)53:9<1849::AID-CNCR2820530909>3.0.CO;2-6","article-title":"Transient encephalopathy during the late course of treatment with high-dose methotrexate","volume":"53","author":"Fritsch","year":"1984","journal-title":"Cancer"},{"key":"R18-4-20210227","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2165\/00128072-200103040-00001","article-title":"Intrathecal chemotherapy with antineoplastic agents in children","volume":"3","author":"Ruggiero","year":"2001","journal-title":"Pediatr Drugs"},{"key":"R19-4-20210227","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/1097-0142(19930101)71:1<117::AID-CNCR2820710119>3.0.CO;2-K","article-title":"Acute neurotoxicity after intrathecal cytosine arabinoside in two adolescents with acute lymphoblastic leukemia of B-cell type","volume":"71","author":"Resar","year":"1991","journal-title":"Cancer"},{"key":"R20-4-20210227","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1200\/JCO.1985.3.5.622","article-title":"Central nervous system morbidity following an initial isolated central nervous system relapse and its subsequent therapy in childhood acute lymphoblastic leukemia","volume":"3","author":"Ochs","year":"1985","journal-title":"J Clin Oncol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0b013e318041f112","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:32:24Z","timestamp":1786033944000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00043426-200704000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e318041f112","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}